SCHEMBL7328425

SCHEMBL7328425

Nc1ccc(-n2nc(-c3cncc(Br)c3)cc2OC(F)F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP8 P40818 1/20 0.38
RAB9A P51151 4/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
NPC1 O15118 3/20 0.37
TSHR P16473 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 1/20 0.36
GFER P55789 1/20 0.36
CYP2A6 P11509 1/20 0.33
PTGS2 P35354 7/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
PDPK1 O15530 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7318548 0.84 MAPT (0.40) USP8RAB9ASMN1; SMN2NPC1MAPT
SCHEMBL7325771 0.75 CRACR2A (0.50) RAB9ASMN1; SMN2NPC1MAPTL3MBTL1
SCHEMBL7327369 0.75 SMN1; SMN2 (0.40) RAB9ASMN1; SMN2NPC1TSHRMAPT
SCHEMBL7319005 0.71 SMN1; SMN2 (0.35) RAB9ASMN1; SMN2NPC1TSHRMAPT
SCHEMBL7322949 0.70 PTGS2 (0.51) TSHRALDH1A1PTGS2CYP1A2CYP3A4
SCHEMBL3374955 0.65 CYP2A6 (0.52) RAB9ASMN1; SMN2NPC1MAPTMEN1
SCHEMBL7324060 0.64 USP8 (0.52) USP8RAB9ASMN1; SMN2NPC1TSHR
SCHEMBL21044243 0.61 PRMT5 (0.49) ALDH1A1TP53CYP1A2CYP3A4CYP2C9
SCHEMBL23119810 0.60 MKNK1 (0.52) MAPTKMT2ACYP2A6
SCHEMBL612307 0.59 CHRNB2 (0.40) L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION ABBOTT LABORATORIES 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044445-A1 AZOLE INHIBITORS OF CYTOKINE PRODUCTION IL5, IL2, IL4 USP8 4088/4885RAB9A 4227/4885SMN1; SMN2 4665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.